Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines), Species Type (Canine, Avian, Feline and Equine), Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Retail Pharmacies and Others) – Industry Trends and Forecast to 2031.
.
The Global Companion Animal Vaccines Market size was valued at USD 3.35 USD Billion in 2023.
The Global Companion Animal Vaccines Market is projected to grow at a CAGR of 5.6% during the forecast period of 2024 to 2031.
The major players operating in the market include Elanco, Boehringer Ingelheim International GmbH, Intervet , Zoetis Services LLC., Bioveta a.s., Sanofi, Bayer AG, Heska Corporation, Virbac, Hester Biosciences Limited, Vetoquinol India Animal Health Pvt Ltd, Phibro Animal Health Corporation, HIPRA, Novartis AG, Merck Sharp & Dohme Corp., Biovet Private Ltd, Ceva,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
